AVH — AVITA Medical Income Statement
0.000.00%
- AU$388.26m
- AU$398.22m
- $64.25m
Annual income statement for AVITA Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14.3 | 29.2 | 34.4 | 50.1 | 64.3 |
Cost of Revenue | |||||
Gross Profit | 11.6 | 23.5 | 28.8 | 42.6 | 55.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 56.9 | 55.8 | 61.9 | 92.8 | 121 |
Operating Profit | -42.7 | -26.5 | -27.5 | -42.7 | -56.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -42 | -26.5 | -26.6 | -35.3 | -61.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -42 | -26.6 | -26.7 | -35.4 | -61.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -42 | -26.6 | -26.7 | -35.4 | -61.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42 | -26.6 | -26.7 | -35.4 | -61.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.06 | -1.17 | -1.06 | -1.39 | -2.37 |